StockNews.com assumed coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a report issued on Tuesday. The brokerage issued a sell rating on the stock.
Ayala Pharmaceuticals Stock Performance
NASDAQ ADXS opened at $0.57 on Tuesday. Ayala Pharmaceuticals has a 12 month low of $0.50 and a 12 month high of $1.95. The stock’s 50 day moving average is $0.71 and its 200 day moving average is $0.75. The stock has a market cap of $6.15 million, a PE ratio of -0.07 and a beta of 1.62.
About Ayala Pharmaceuticals
Featured Stories
- Five stocks we like better than Ayala Pharmaceuticals
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Comprehensive Analysis of PayPal Stock
- When to Sell a Stock for Profit or Loss
- Intuitive Surgical Stock Can Trend Much Higher This YearÂ
- 5 discounted opportunities for dividend growth investors
- Alibaba Stock Analysis: Insights, Trends, and Future Predictions
Receive News & Ratings for Ayala Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ayala Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.